Severe and enduring anorexia nervosa (SE-AN): in search of a new paradigm
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Anorexia nervosa is one of the earliest psychiatric illnesses to be described in the medical literature with well documented accounts made in the 19th century by both Gull [1] and Lasegue [2]. They both expressed optimism about the eventual outcome of treatment. Since then, there have been many claims about successful outcomes, but all too often only reversal of the undernourished state is achieved [3]. Treatment may have minimal impact on the persistent and unrelenting ruminations pertaining to food, shape and weight which are so characteristic of those with SE-AN. Good progress has been made in treating younger patients with a shorter duration of illness using family-based approaches [4, 5] but it is those who either fail to respond, or go on to develop a severe and enduring form of the disorder (SE-AN), that have received little or no attention to date [6]. Those living with a chronic illness, especially one as debilitating as SE-AN, are entitled to dream of a better tomorrow and to feel understood not only by the medical profession but by the world at large [7]. Almost every day, we are reminded about the extra-ordinary breakthroughs being made in the fight against cancer, whilst we continue to battle over the vexed issues of the imposition of involuntary treatment and the ethics of palliative care. Patients with SE-AN can no longer be ignored for they have suffered for far too long, having to contend with an abysmal quality of life devoid of any hope of an effective treatment on the horizon. This situation is in urgent need of address especially since there has only been one randomised controlled trial to date [8] that has specifically focussed upon those with the severe and enduring form of the illness. Much more needs to be done. The time has now arrived to take the bold step in reconceptualising illness severity in anorexia nervosa especially since there is a growing recognition that the factors that may contribute towards its onset are not necessarily the same as the ones that may perpetuate it [9]. Our current classification system (DSM-5), although an improvement over its predecessors, remains limited in its clinical utility especially when identifying the onset of illness (when treatment is most likely to be effective) and giving special recognition to those when it becomes persistent [10, 11]. We have provided a cogent argument that a clinical staging model, that is so widespread in the conceptualisation and treatment of somatic illness, be adopted in anorexia nervosa. Such a model has been applied in malignancies, cardiac failure, auto-immune disease and burns where both prognosis and treatment are informed by stage [12]. Anorexia nervosa is ideally suited for the adoption of a staging model, because unlike any other psychiatric disorder, it has clearly delineated physical biomarkers of disease progression, for example bradycardia and raised liver enzymes [13] Like so many illnesses, anorexia nervosa exists on a spectrum. Just as there is no single treatment advocated for all cancers, there should not only be one treatment for all patients with anorexia nervosa. It is clear that a 14 year old adolescent with a 3 month history of anorexia nervosa would present differently to a 40 year old woman who has battled the illness for 25 years with multiple hospital admissions and has attempted cognitive behaviour therapy several times. Those with SE-AN are more likely to have high levels of disability, to be under- or unemployed, to be receiving welfare, supported by health benefit plans and become a significant burden to family, carers and health fund providers. In fact on measures such as quality of life, those with SE-AN have been found to be equal in impairment to those with severe depressive disorder as well as schizophrenia [14]. Such factors provide a compelling argument as to why a rehabilitation model of care, not too dissimilar to the ones advocated for those with schizophrenia, needs to be considered for those with a persistent eating disorder including highly specialised acute care when the need arises. It goes without saying that such patients with SE-AN are amongst the most challenging found in mental health care [15]. They have a markedly reduced life expectancy with the highest mortality rate of any mental illness (at 20 years the mortality rate is 20 %). Because the onset of anorexia nervosa occurs at a young age, it is unfortunately not uncommon for death to occur in young adults in their thirties with a further 5-10 % every decade thereafter [16]. They suffer from a myriad of medical complications and are frequent but often reluctant visitors to general and specialist medical facilities as well as primary care services [6]. Most patients with SE-AN are unlikely to fully recover. Some do but they are in the minority. It is therefore extremely important not to focus solely upon symptom reduction, but to also take into account a more holistic model of care. Such a’ recovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The outcome of anorexia nervosa in the 20th century
Steinhausen, H.-C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1284 · Cited by 1,761
Treasure, J., Stein, D., & Maguire, S. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12170 · Cited by 353
Treating severe and enduring anorexia nervosa: a randomized controlled trial
Touyz, S., Le Grange, D., Lacey, H., Hay, P., Smith, R., Maguire, S., Bamford, B., Pike, K. M., & Crosby, R. D. (2013) · Psychological Medicine · doi:10.1017/s0033291713000949 · Cited by 291
Self-citationNew treatment approaches for severe and enduring eating disorders
Treasure, J., Cardi, V., Leppanen, J., & Turton, R. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.007 · Cited by 91 · cited 2×
“of investigation such as deep brain stimulation [18, 21] and transcranial magnetic stimulation [18, 22].”
BackgroundThe recovery model and anorexia nervosa
Dawson, L., Rhodes, P., & Touyz, S. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414539398 · Cited by 81
Self-citation
Cited by
Trachsel, M., Irwin, S. A., Biller-Andorno, N., Hoff, P., & Riese, F. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0970-y · Cited by 148
Broomfield, C., Stedal, K., Touyz, S., & Rhodes, P. (2017) · International Journal of Eating Disorders · doi:10.1002/eat.22715 · Cited by 126
Terminal anorexia nervosa: three cases and proposed clinical characteristics
Gaudiani, J. L., Bogetz, A., & Yager, J. (2022) · Journal of Eating Disorders · doi:10.1186/s40337-022-00548-3 · Cited by 82
Calabrese, L., Scolnick, B., Zupec-Kania, B., Beckwith, C., Costello, K., & Frank, G. K. W. (2022) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · doi:10.1007/s40519-022-01455-x · Cited by 56
“The mortality rate of AN is among the highest among the psychiatric disorders, but there is no FDA-approved medication for the treatment of AN, and the effectiveness of psychotherapeutic interventions especially for severe and enduring AN is limited [1].”
Downs, J., Ayton, A., Collins, L., Baker, S., Missen, H., & Ibrahim, A. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00400-x · Cited by 51
Metadata
- Authors
- Touyz, S., & Hay, P.
- Venue
- Journal of Eating Disorders
- Published
- 2015-07-31
- Volume
- 3
- Issue
- 1
- Pages
- 26-26
- ISSN
- 2050-2974 (ISSN-L)
- OpenAlex
- W1823794116
- Cited by
- 90
- References
- 5
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severe and enduring anorexia nervosa (SE-AN): in search of a new paradigm. https://app.cochat.ai/papers/10.1186/s40337-015-0065-z
- The paper
- Touyz, S., & Hay, P. (2015). Severe and enduring anorexia nervosa (SE-AN): in search of a new paradigm. Journal of Eating Disorders. https://doi.org/10.1186/s40337-015-0065-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.